<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>AmitisGen TECH Dev Group</PublisherName>
				<JournalTitle>Personalized and Precision Medicine Journal</JournalTitle>
				<Issn>3115-7874</Issn>
				<Volume>7</Volume>
				<Issue>27</Issue>
				<PubDate PubStatus="epublish">
					<Year>2022</Year>
					<Month>12</Month>
					<Day>20</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Your Body on a Chip: Functional Testing for Personalized Medicine</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>1</FirstPage>
			<LastPage>7</LastPage>
			<ELocationID EIdType="pii">700885</ELocationID>
			
<ELocationID EIdType="doi">10.22034/pmj.2022.700885</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Mona</FirstName>
					<LastName>Aghassizadeh-Sherbaf</LastName>
<Affiliation>Department of Microbiology, Faculty of Basic Sciences, East-Tehran Branch, Islamic Azad University, Tehran, Iran.</Affiliation>

</Author>
<Author>
					<FirstName>Jumi</FirstName>
					<LastName>Bora</LastName>
<Affiliation>Department of Zoology, The Assam Royal Global University, Guwahati, Assam, India.</Affiliation>

</Author>
<Author>
					<FirstName>Aynaz</FirstName>
					<LastName>Mazandarani</LastName>
<Affiliation>Department of Biochemistry, Faculty of Basic Sciences, University of Mazandaran, Babolsar, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2022</Year>
					<Month>08</Month>
					<Day>07</Day>
				</PubDate>
			</History>
		<Abstract>Despite the well-known high prevalence of failure in drug development, recent advancements in tissue engineering and microfabrication have helped to create microphysiological systems (MPS), or &quot;organs-on-chips,&quot; which mimic the function of human organs. These &quot;tissue chips&quot; might be used for toxicity and drug screening tests, which could revolutionize the early phases of the drug development process. Additionally, they may be utilized to simulate disease conditions, supplying new instruments for deciphering disease pathologies and causes and evaluating the efficacy of novel treatments. Future clinical trials on chips might be utilized to assess novel medicines in both populations and individuals, opening the door for precision medicine. Here, we&#039;ll discuss tissue chips&#039; diverse potential and the difficulties in developing them.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Drug development</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Tissue chips</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Personalized Medicine</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.pmjournal.ir/article_700885_f72948ec5cb1ebd5aab3f161b4db742f.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
